This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home points on Trastuzumab Deruxtecan ENHERTU®.  2023-2024 SGO Chemotherapy and Targeted Therapies Sub ..read more

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®.  Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®.  Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MD Speakers:Jenn ..read more

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®.   2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MD Speakers:Jennifer MacDonald, PharmD, BC ..read more

This is the second of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Lenvatinib/pembrolizumab. Focusing on specialty pharmacy and patient education when taking Lenvatinib at home. The session ends with general take home points on administration and toxicity prevention interventions.  2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith A. Smith, B.S., P ..read more

This is the first of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. After going over some general information on Lenvatinib/pembrolizumab including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologic Oncologist educated and prepared for giving Lenvatinib/pembrolizumab. The session wraps up with some key take home points on Lenvatinib/pembrolizumab.   2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith A. Smi ..read more

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS). Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity.  Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (S ..read more

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center Sarah Hayward ..read more

Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.    Some questions covered during the interview:  Since NRG just celebrated its 10-year anniversary during the Summer Meeting, what is the vision for NRG in the next 10 years? What are some of the successes within the past year for the Ovary Subcommittee? What were the most important highlights from the Cervix and Vulvar Subcommit ..read more

Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer.  Host/Moderator: Leigh A. Cantrell, MD, MSPH Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of Virginia Guest Speaker: Kara Romano, M.D. Assistant Professor, Department of Radiation Oncology - University of Virginia Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology ..read more

Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials.    Some topics covered during the interview: Barriers to clinical trial enrollment and retention among racially and ethnically diverse patient populations. Role of cooperative research groups in improving access to clinical trials for racially and ethnically diverse patient populations.  Discussion of r ..read more